Page last updated: 2024-08-24

imiquimod and Vulvar Neoplasms

imiquimod has been researched along with Vulvar Neoplasms in 106 studies

Research

Studies (106)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	39 (36.79)	29.6817
2010's	55 (51.89)	24.3611
2020's	12 (11.32)	2.80

Authors

Authors	Studies
Boll, D; Bulten, J; de Hullu, JA; Esajas, MD; Meeuwis, KA; van Beurden, M; van der Linden, M; van Dorst, EB; van Hees, CL; van Poelgeest, MI	1
Boandl, A; Bogner, G; Ciresa-König, A; Holter, M; Jan, Z; Joura, EA; Kalteis, MS; Regauer, S; Reich, O; Schauer, C; Tamussino, K; Trutnovsky, G; Widschwendter, A	1
Jordanova, ES; van Beurden, M; Voss, FO	1
Benedetto, C; Bertero, L; Borella, F; Gallio, N; Micheletti, L; Pérez-López, FR; Preti, M; Vieira-Baptista, P	1
Bevilacqua, F; Bleeker, MCG; Bornstein, J; Carcopino, X; Chargari, C; Cruickshank, ME; Erzeneoglu, BE; Esat Temiz, B; Gallio, N; Gultekin, M; Heller, D; Joura, E; Kesic, V; Planchamp, F; Preti, M; Querleu, D; Reich, O; Stockdale, CK; Van Beurden, M; Vieira-Baptista, P; Woelber, L; Zodzika, J	1
Bevilacqua, F; Bleeker, MCG; Bornstein, J; Carcopino, X; Chargari, C; Cruickshank, ME; Erzeneoglu, BE; Gallio, N; Gultekin, M; Heller, D; Joura, E; Kesic, V; Planchamp, F; Preti, M; Querleu, D; Reich, O; Stockdale, CK; Temiz, BE; Van Beurden, M; Vieira-Baptista, P; Woelber, L; Zodzika, J	1
Alvarez-Mendoza, C; Hurt, CN; Jones, S; Nedjai, B; Powell, N; Tristram, A	1
Benedetto, C; Bertero, L; Borella, F; Cassoni, P; Gallio, N; Mangherini, L; Preti, M	1
Assil, S; Burggraaf, J; Buters, TP; Feiss, G; Florencia, E; Klaassen, ES; Moerland, M; Niemeyer-van der Kolk, T; Prens, EP; Rijsbergen, M; Rissmann, R; van Doorn, MBA	1
Abdulrahman, Z; de Miranda, NFCC; de Vos van Steenwijk, PJ; Hellebrekers, BWJ; van der Burg, SH; van Esch, EMG; van Poelgeest, MIE	1
Carton, I; Henno, S; Lavoué, V; Lebreton, M; Levêque, J; Nyangoh-Timoh, K; Tesson, C	1
Benedetto, C; Bertero, L; Bevilacqua, F; Borella, F; Carosso, AR; Cassoni, P; Castellano, I; Collemi, G; Cosma, S; Gallio, N; Micheletti, L; Preti, M	1
Hutson, R; Nama, V; Parashurama, R	1
Bryant, D; Fiander, AN; Hibbitts, S; Hurt, CN; Jones, SEF; Powell, N; Tristram, AJ	1
Carucci, M; Fiander, A; Hurt, CN; Jones, S; Madden, TA; Naik, R; Nordin, AJ; Powell, N; Tristram, A	1
Helm, CW	1
de Figueiredo E Silva Rama, AL; de Gois Speck, NM; Nogueira de Carvalho, CR; Ribalta, JCL; Schimidt, MA	1
Meinert, M; Vorbeck, CS; Østergård, S	1
Millán-Cayetano, JF; Padilla-España, L; Repiso-Jiménez, JB	1
Khatun, A; Lotery, H; Sundaram, S	1
Calonje, E; Craythorne, E; Lewis, F; Nath, R; Veraitch, O	1
Bulten, J; de Hullu, JA; Fons, G; Lok, CAR; Massuger, LFAG; Oonk, MHM; Slangen, BMF; van der Linden, M; van Doorn, HC; van Dorst, EBL; van Poelgeest, MIE	1
Brinkmann, D; Christie, C; Harvey, G; Hughes, BR; Pontefract, D	1
Innamaa, A; Lippiatt, J; Melson, L; Mujukian, A	1
Bouceiro-Mendes, R; Correia-Fonseca, I; Mendonça-Sanches, M; Soares-de-Almeida, L	1
Allan, E; Bryant, A; Cooper, S; Edey, KA; Murdoch, JB	1
Assorgi, C; Biamonti, A; Catalano, A; Cozza, G; Frega, A; Gentile, M; Lombardi, D; Maniglio, P; Marziani, R; Milazzo, GN; Moscarini, M; Ricciardi, E; Scirpa, P; Sesti, F; Sopracordevole, F	1
Nelson, EL; Stockdale, CK	1
Innamaa, A; Palmer, J; Sanderson, P; Tidy, J	1
Buttmann, N; Clad, A; Gieseking, F; Harter, P; Lellé, RJ; Luyten, A; Maass-Poppenhusen, K; Petry, KU; Sörgel, P	1
Berasategui, MT; Gogorza, S; Lopez, DG; Marchitelli, C; Peremateu, MS; Sluga, MC; Velazco, A; Wernicke, A	1
Mahner, S; Wölber, L	1
Dutton, P; Fiander, A; Griffiths, G; Hibbitts, S; Hurt, CN; Jones, S; Madden, T; Man, S; Naik, R; Nordin, AJ; Powell, N; Tristram, A	1
Biamonti, A; Bianchi, P; Caserta, D; Catalano, A; Cozza, G; Di Martino, G; Frega, A; Gentile, M; Marziani, R; Milazzo, GN; Schimberni, M; Scirpa, P; Sesti, F; Sopracordevole, F; Zinna, M	1
Machida, H; Matsuo, K; Moeini, A; Roman, LD	1
Bryant, A; Kaushik, S; Lawrie, TA; Nordin, A; Pepas, L	1
de Witte, CJ; Gerestein, CG; Koeneman, MM; Kruse, AJ; van Beekhuizen, HJ; van de Sande, AJ	1
Conway, K; Lewis, F; Sethi, G; Toby, M	1
Bryant, A; Chakrabarti, M; Kaushik, S; Lawrie, TA; Nordin, A; Pepas, L	1
Berends-van der Meer, DM; Bosse, T; Daemen, T; Fathers, LM; Fleuren, GJ; Hamming, IL; Hellebrekers, BW; Hollema, H; Kagie, MJ; Kenter, GG; Loof, NM; Löwik, MJ; Melief, CJ; Nijman, HW; Oostendorp, J; Oude Elberink, JH; Schreuder, HW; Stijnen, T; Stynenbosch, LF; Trimbos, JB; Valentijn, AR; van Beurden, M; van der Burg, SH; van Esch, EM; van Poelgeest, MI; Vermeij, R; Welters, MJ	1
Aw, CW; Liau, MM; Tan, KB; Yang, SS	1
Cetin, C; Dogan, A; Grimm, C; Hefler, LA; Hilal, Z; Krentel, H; Tempfer, CB	1
Alouini, S; Mathevet, P	1
Kreuter, A	1
Daayana, S; Elkord, E; Kitchener, HC; Lear, JT; Stern, PL; Tomlinson, AE; Winters, U	1
Geisler, JP; Manahan, KJ	1
Challenor, R; Fitton, AR; Hughes, G	1
Festa Neto, C; Niwa, AB; Sanches, JA; Tanaka, VD; Torezan, L	1
Benito, DM; Casado, M; Feito, M; Feltes, R; Floristán, U; Herranz, P; Ramírez, P; Sendagorta, E	1
Mahto, M; Nathan, M; O'Mahony, C	1
Daayana, S; Elkord, E; Kitchener, HC; Pawlita, M; Roden, R; Stern, PL; Winters, U	1
Bertozzi, S; Fruscalzo, A; Lellé, RJ; Londero, AP; Marchesoni, D	1
Beckmann, I; Blok, LJ; Heijmans-Antonissen, C; Helmerhorst, TJ; Kleinjan, A; Santegoets, LA; Terlou, A; van Beurden, M; van Seters, M	2
Liu, XS	1
Güngor, T; Ozat, M; Sahin, I; Sirvan, L; Tonguc, E; Var, T	1
Crawford, RI; Sadownik, LA	1
Bhalerao-Gandhi, A; Khan, KJ; Madnani, NA	1
Aaronson, NK; Blok, LJ; Ewing, PC; Gundy, CM; Heijmans-Antonissen, C; Helmerhorst, TJ; Quint, WG; Terlou, A; van Beurden, M; van Seters, M	1
Kondo, E; Motohashi, T; Okugawa, T; Sagawa, N; Shiozaki, T; Tabata, T; Tanida, K; Toriyabe, K	1
Bryant, A; Dickinson, HO; Kaushik, S; Nordin, A; Pepas, L	1
Badger, J; Dadras, SS; Kong, CS; Taube, JM	1
Gómez-Moyano, E; Hiraldo-Gamero, A; Sánchez-Fajardo, F; Sanz-Trelles, A; Segura-Palacios, JM	1
Anton, C; Baracat, EC; Carvalho, FM; Carvalho, JP; Luiz, AV	1
Cerio, R; Gibbon, K; Harwood, CA; Matin, RN; Rizvi, H	1
Badiglian-Filho, L; Baiocchi, G; Begnami, MD; Costa, FD; Faloppa, CC; Fukazawa, EM; Kumagai, LY; Oliveira, RA; Soares, FA; Surima, WS	1
Bogatch, K; Carvajal, RD; Chapman, PB; Chi, DS; Costantino, PD; Flavin, M; Gardner, GJ; Pulitzer, MP; Schwartz, GK; Smyth, EC; Wolchok, JD	1
Kaushal, S; Kopparthy, P; Merideth, M; Pulanic, TK; Stratton, P	1
Borrego, J; Figueiredo, A; Paula, T; Ribeiro, F	1
Feito, M; Gómez-Fernandez, C; Herranz, P; Sendagorta, E	1
Gormley, RH; Kovarik, CL	1
Brown, J; Frumovitz, M; Milbourne, AM; Munsell, MF; Rhodes, HE; Schmeler, KM; Trimble, CL; Wallbillich, JJ	1
Clad, A; Fischer, A; Westermann, C	1
Fons, G; van Beurden, M; van Seters, M	1
Krumholz, BA; Travis, LB; Weinberg, JM	1
Godfrey, JC; Vaughan, MC; Williams, JV	1
Campagne, G; Martínez, A; Roca, M	1
Dorn, C; Kupka, M; Petrow, W; Richter, ON; Ulrich, U; Wardelmann, E	1
Blanchard, A; Busbey, S; Judge, DE; Lorincz, AA; Medenica, MM; Wang, LC	1
Barton, S; Berman, B; Hengge, U	1
Etherington, I; Luesley, DM; Steele, JC; Todd, RW	1
Cox, JT; Petry, KU; Roy, M; Rylander, E	1
Baroni, A; Rossiello, L; Ruocco, E; Ruocco, V	1
Berville-Levy, S; Bourgault-Villada, I; Clerici, T; Moyal-Barracco, M; Saiag, P; Wendling, J	1
Lugones, L; Marchitelli, C; Perrotta, M; Pesce, R; Secco, G; Testa, R	1
Maw, RD	1
Drijfhout, JW; Heijmans-Antonissen, C; Helmerhorst, TJ; Kenter, GG; Kwappenberg, KM; Melief, CJ; Offringa, R; van Beurden, M; van der Burg, SH; van Poelgeest, MI; van Seters, M	1
Costa, RR; de Freitas, VG; de Góis, NM; Kesselring, F; Kobata, MP; Ribalta, JC; Taha, NS	1
Downs, AM; Geraghty, JM; Jones, C	1
Kim, JW; Kim, YJ; Koh, BK	1
Fung, MF; Hicks, W; Hopkins, L; Le, T; Menard, C	1
Cruickshank, DJ; Lonsdale-Eccles, AA; Morgan, JM; Nagarajan, S	1
McQuillan, O; Morgan, E	1
Bruchim, I; Ferenczy, A; Gotlieb, WH; Grzywacz, K; Mahmud, S; Tunitsky, E	1
Fung-Kee-Fung, M; Hicks-Boucher, W; Hopkins, L; Le, T; Menard, C; Weberpals, J	1
Buus, SK; Cramers, M; Mathiesen, O	1
Athanasiou, S; Falagas, ME; Iavazzo, C; Pitsouni, E	1
de Hullu, JA; Massuger, LF; van de Nieuwenhof, HP; van der Avoort, IA	1
Davis, JR; Hatch, KD	1
Aaronson, NK; Beckmann, I; Burger, MP; Eijkemans, MJ; Ewing, PC; Heijmans-Antonissen, C; Helmerhorst, TJ; Kagie, MJ; Kleinjan, A; Meijer, CJ; ten Kate, FJ; van Beurden, M; van Seters, M; Zijlstra, FJ	1
Davis, G; Richard, J; Wentworth, J	1
Arany, I; Diaz-Arrastia, C; Dinh, TV; Gatalica, Z; Hannigan, E; Robazetti, SC; Tyring, SK	1
Bieber, T; Gerdsen, R; Petrow, W; Richter, O; Uerlich, M	1
Etherington, IJ; Luesley, DM; Todd, RW	1
Jayne, CJ; Kaufman, RH	1

Reviews

22 review(s) available for imiquimod and Vulvar Neoplasms

Article	Year
Recent advances in treating female genital human papillomavirus related neoplasms with topical imiquimod. Journal of medical virology, 2023, Volume: 95, Issue:11 Topics: Adjuvants, Immunologic; Female; Human Papillomavirus Viruses; Humans; Imiquimod; Papillomaviridae; Papillomavirus Infections; Uterine Cervical Neoplasms; Vagina; Vulvar Neoplasms	2023
Paget's disease of the vulva: A challenge for the gynaecologist. Journal of gynecology obstetrics and human reproduction, 2021, Volume: 50, Issue:1 Topics: Administration, Topical; Antineoplastic Agents; Diagnosis, Differential; Female; Humans; Imiquimod; Lasers, Gas; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Photochemotherapy; Prognosis; Radiotherapy Dosage; Vulvar Neoplasms	2021
Is There a Place for Immune Checkpoint Inhibitors in Vulvar Neoplasms? A State of the Art Review. International journal of molecular sciences, 2020, Dec-27, Volume: 22, Issue:1 Topics: Adjuvants, Immunologic; Alphapapillomavirus; Antineoplastic Agents; Carcinoma, Squamous Cell; Female; Humans; Imiquimod; Immune Checkpoint Inhibitors; Immunotherapy; Melanoma; Neuroendocrine Tumors; Paget Disease, Extramammary; Prognosis; Vulvar Neoplasms	2020
[Vulvar intraepithelial neoplasia]. Ugeskrift for laeger, 2018, 05-14, Volume: 180, Issue:20 Topics: Antineoplastic Agents; Carcinoma in Situ; Female; Humans; Imiquimod; Immunocompromised Host; Papillomaviridae; Papillomavirus Infections; Papillomavirus Vaccines; Precancerous Conditions; Vulvar Neoplasms	2018
Interventions for the treatment of Paget's disease of the vulva. The Cochrane database of systematic reviews, 2019, 06-05, Volume: 6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Female; Humans; Imiquimod; Laser Therapy; Middle Aged; Paget Disease, Extramammary; Photochemotherapy; Randomized Controlled Trials as Topic; Vulvar Neoplasms	2019
Imiquimod therapy for extramammary Paget's disease of the vulva: a viable non-surgical alternative. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2013, Volume: 33, Issue:5 Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Anti-Inflammatory Agents; Antineoplastic Agents; Clobetasol; Female; Humans; Imiquimod; Middle Aged; Paget Disease, Extramammary; Vulvar Neoplasms	2013
Effects of imiquimod on vulvar Paget's disease: a systematic review of literature. Gynecologic oncology, 2015, Volume: 139, Issue:1 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Paget Disease, Extramammary; Treatment Outcome; Vulvar Neoplasms	2015
Medical interventions for high-grade vulval intraepithelial neoplasia. The Cochrane database of systematic reviews, 2015, Aug-18, Issue:8 Topics: Administration, Topical; Adult; Aminoquinolines; Anticarcinogenic Agents; Antineoplastic Agents; Carcinoma in Situ; Cidofovir; Cytosine; Female; Humans; Imiquimod; Indoles; Organophosphonates; Randomized Controlled Trials as Topic; Vulvar Neoplasms	2015
Imiquimod in cervical, vaginal and vulvar intraepithelial neoplasia: a review. Gynecologic oncology, 2015, Volume: 139, Issue:2 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Female; Humans; Imiquimod; Papillomavirus Infections; Treatment Outcome; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vaginal Neoplasms; Vulvar Neoplasms	2015
Medical and surgical interventions for the treatment of usual-type vulval intraepithelial neoplasia. The Cochrane database of systematic reviews, 2016, Jan-05, Issue:1 Topics: Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Cidofovir; Cytosine; Disease Progression; Female; Humans; Imiquimod; Indoles; Laser Therapy; Neoplasm Recurrence, Local; Organophosphonates; Photochemotherapy; Prospective Studies; Randomized Controlled Trials as Topic; Retrospective Studies; Treatment Outcome; Vulvar Neoplasms	2016
Paget's Disease of the Vulva Treated with Imiquimod: Case Report and Systematic Review of the Literature. Gynecologic and obstetric investigation, 2017, Volume: 82, Issue:1 Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Paget Disease, Extramammary; Skin Cream; Vulvar Neoplasms	2017
More than a decade on: review of the use of imiquimod in lower anogenital intraepithelial neoplasia. International journal of STD & AIDS, 2010, Volume: 21, Issue:1 Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Anus Neoplasms; Carcinoma in Situ; Female; HIV Infections; Humans; Imiquimod; Male; Middle Aged; Penile Neoplasms; Randomized Controlled Trials as Topic; Treatment Outcome; Vulvar Neoplasms	2010
[Paget disease of the vulva: resolution after local treatment with imiquimod--report of a case and review of the literature]. Gynakologisch-geburtshilfliche Rundschau, 2009, Volume: 49, Issue:4 Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Chemotherapy, Adjuvant; Colposcopy; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Imiquimod; Laser Therapy; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Vulva; Vulvar Neoplasms	2009
Treatment of recurrent vulvar Paget disease with imiquimod cream: a case report and review of the literature. Archives of gynecology and obstetrics, 2011, Volume: 283, Issue:1 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Betamethasone; Emollients; Female; Humans; Imiquimod; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Treatment Outcome; Vulvar Neoplasms	2011
Medical interventions for high grade vulval intraepithelial neoplasia. The Cochrane database of systematic reviews, 2011, Apr-13, Issue:4 Topics: Administration, Topical; Adult; Aminoquinolines; Anticarcinogenic Agents; Antineoplastic Agents; Carcinoma in Situ; Female; Humans; Imiquimod; Indoles; Randomized Controlled Trials as Topic; Vulvar Neoplasms	2011
Differentiated (simplex) vulvar intraepithelial neoplasia: a case report and review of the literature. The American Journal of dermatopathology, 2011, Volume: 33, Issue:3 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Female; Humans; Imiquimod; Lichen Sclerosus et Atrophicus; Precancerous Conditions; Vulvar Neoplasms	2011
Human papillomavirus-related genital disease in the immunocompromised host: Part II. Journal of the American Academy of Dermatology, 2012, Volume: 66, Issue:6 Topics: Adjuvants, Immunologic; Alphapapillomavirus; Aminoquinolines; Antineoplastic Agents, Phytogenic; Antiviral Agents; Anus Neoplasms; Buschke-Lowenstein Tumor; Catechin; Caustics; Cidofovir; Condylomata Acuminata; Counseling; Cryotherapy; Cytosine; Female; Humans; Imiquimod; Immunocompromised Host; Male; Ointments; Organophosphonates; Papillomavirus Infections; Penile Neoplasms; Podophyllotoxin; Precancerous Conditions; Treatment Outcome; Trichloroacetic Acid; Vaginal Neoplasms; Vulvar Neoplasms; Warts	2012
Successful treatment of bowenoid papulosis in a 9-year-old girl with vertically acquired human immunodeficiency virus. Pediatrics, 2003, Volume: 112, Issue:1 Pt 1 Topics: Acquired Immunodeficiency Syndrome; Adult; Aminoquinolines; Antineoplastic Agents, Phytogenic; Bowen's Disease; Child; Female; Humans; Imiquimod; Infectious Disease Transmission, Vertical; Maternal-Fetal Exchange; Papillomaviridae; Papillomavirus Infections; Perineum; Podophyllin; Pregnancy; Pregnancy Complications, Infectious; Remission Induction; Skin Neoplasms; Tumor Virus Infections; Vulvar Neoplasms	2003
Bowenoid papulosis of the vulva-immunotherapeutical approach with topical imiquimod. Archives of gynecology and obstetrics, 2003, Volume: 268, Issue:4 Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aminoquinolines; Bowen's Disease; Carcinoma in Situ; Carcinoma, Squamous Cell; Diabetes Mellitus, Type 1; Female; Humans; Imiquimod; Immunotherapy; Papillomaviridae; Papillomavirus Infections; Vulvar Neoplasms	2003
Successful management of viral infections and other dermatoses with imiquimod 5% cream. Acta dermato-venereologica. Supplementum, 2003, Issue:214 Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Aged, 80 and over; Aminoquinolines; Carcinoma in Situ; Child; Condylomata Acuminata; Female; Humans; Imiquimod; Keloid; Male; Middle Aged; Molluscum Contagiosum; Skin Diseases; Virus Diseases; Vulvar Neoplasms	2003
Using imiquimod for genital warts in female patients. Journal of women's health (2002), 2004, Volume: 13, Issue:3 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Condylomata Acuminata; Female; Genital Diseases, Female; Humans; Imiquimod; Interferon Inducers; Papillomaviridae; Quality of Life; Recurrence; Risk Factors; Viral Load; Vulvar Neoplasms; Women's Health	2004
Imiquimod for treatment of vulvar and vaginal intraepithelial neoplasia. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2008, Volume: 101, Issue:1 Topics: Administration, Cutaneous; Administration, Intravaginal; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Female; Humans; Imiquimod; Precancerous Conditions; Treatment Outcome; Vaginal Neoplasms; Vulvar Neoplasms	2008

Trials

18 trial(s) available for imiquimod and Vulvar Neoplasms

Article	Year
Topical imiquimod versus surgery for vulvar intraepithelial neoplasia: a multicentre, randomised, phase 3, non-inferiority trial. Lancet (London, England), 2022, 05-07, Volume: 399, Issue:10337 Topics: Female; Humans; Imiquimod; Lactation; Papillomavirus Infections; Pregnancy; Squamous Intraepithelial Lesions; Vulvar Neoplasms	2022
Combined HPV 16 E2 and L1 methylation predict response to treatment with cidofovir and imiquimod in patients with vulval intraepithelial neoplasia. Cancer biomarkers : section A of Disease markers, 2022, Volume: 35, Issue:2 Topics: Aminoquinolines; Biomarkers; Cidofovir; DNA Methylation; Female; Human papillomavirus 16; Humans; Imiquimod; Papillomavirus Infections; Prospective Studies; Uterine Cervical Neoplasms; Vulvar Neoplasms	2022
Omiganan Enhances Imiquimod-Induced Inflammatory Responses in Skin of Healthy Volunteers. Clinical and translational science, 2020, Volume: 13, Issue:3 Topics: Administration, Cutaneous; Adolescent; Adult; Alphapapillomavirus; Antimicrobial Cationic Peptides; Carcinoma in Situ; Condylomata Acuminata; Drug Synergism; Drug Therapy, Combination; Female; Healthy Volunteers; Humans; Imiquimod; Male; Middle Aged; Proof of Concept Study; Skin; Vulvar Neoplasms; Young Adult	2020
Recurrence of vulval intraepithelial neoplasia following treatment with cidofovir or imiquimod: results from a multicentre, randomised, phase II trial (RT3VIN). BJOG : an international journal of obstetrics and gynaecology, 2018, Volume: 125, Issue:9 Topics: Administration, Topical; Antineoplastic Agents; Carcinoma in Situ; Cidofovir; Female; Humans; Imiquimod; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Treatment Outcome; Vulvar Neoplasms	2018
Activity, safety, and feasibility of cidofovir and imiquimod for treatment of vulval intraepithelial neoplasia (RT³VIN): a multicentre, open-label, randomised, phase 2 trial. The Lancet. Oncology, 2014, Volume: 15, Issue:12 Topics: Adult; Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Carcinoma in Situ; Cidofovir; Cytosine; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Imiquimod; Middle Aged; Neoplasm Grading; Organophosphonates; Vulvar Neoplasms	2014
Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell Response. Clinical cancer research : an official journal of the American Association for Cancer Research, 2016, 05-15, Volume: 22, Issue:10 Topics: Adult; Aged; Aminoquinolines; Cancer Vaccines; Carcinoma in Situ; CD8-Positive T-Lymphocytes; Female; Human papillomavirus 16; Humans; Imiquimod; Interferon-gamma; Middle Aged; Oncogene Proteins, Viral; Papillomavirus E7 Proteins; Papillomavirus Infections; Papillomavirus Vaccines; Uterine Cervical Neoplasms; Vaccination; Vaginal Neoplasms; Vulvar Neoplasms; Young Adult	2016
Clinical and immunologic results of a phase II trial of sequential imiquimod and photodynamic therapy for vulval intraepithelial neoplasia. Clinical cancer research : an official journal of the American Association for Cancer Research, 2008, Aug-15, Volume: 14, Issue:16 Topics: Administration, Topical; Adult; Aminoquinolines; Antigens, CD; Antineoplastic Agents; Carcinoma in Situ; Combined Modality Therapy; Female; Fluorescent Antibody Technique; Humans; Imiquimod; Immunohistochemistry; Lymphocytes, Tumor-Infiltrating; Middle Aged; Photochemotherapy; T-Lymphocytes, Regulatory; Vulvar Neoplasms	2008
Phase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia. British journal of cancer, 2010, Mar-30, Volume: 102, Issue:7 Topics: Adolescent; Adult; Aged; Aminoquinolines; Antigens, Viral; Antineoplastic Combined Chemotherapy Protocols; Cancer Vaccines; Carcinoma in Situ; Drug Tolerance; Female; Human papillomavirus 16; Humans; Imiquimod; Middle Aged; Papillomavirus Vaccines; Vulvar Neoplasms; Young Adult	2010
Treatment of vulvar intraepithelial neoplasia with topical imiquimod: seven years median follow-up of a randomized clinical trial. Gynecologic oncology, 2011, Volume: 121, Issue:1 Topics: Adult; Aminoquinolines; Antineoplastic Agents; Body Image; Carcinoma in Situ; Carcinoma, Squamous Cell; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; Humans; Imiquimod; Middle Aged; Neoplasm Invasiveness; Quality of Life; Sexuality; Vulvar Neoplasms	2011
Imiquimod in the treatment of multifocal vulvar intraepithelial neoplasia 2/3. Results of a pilot study. The Journal of reproductive medicine, 2002, Volume: 47, Issue:9 Topics: Administration, Topical; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Female; Humans; Imiquimod; Middle Aged; Neoplasm Staging; Pilot Projects; Prospective Studies; Time Factors; Vaginal Creams, Foams, and Jellies; Vulvar Neoplasms	2002
Treatment of undifferentiated vulvar intraepithelial neoplasia with 5% imiquimod cream: a prospective study of 12 cases. Archives of dermatology, 2004, Volume: 140, Issue:10 Topics: Administration, Cutaneous; Adult; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Middle Aged; Papillomaviridae; Precancerous Conditions; Prospective Studies; Treatment Outcome; Vulvar Neoplasms	2004
Treatment of bowenoid and basaloid vulvar intraepithelial neoplasia 2/3 with imiquimod 5% cream. The Journal of reproductive medicine, 2004, Volume: 49, Issue:11 Topics: Administration, Topical; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Female; Humans; Imiquimod; Middle Aged; Papillomavirus Infections; Treatment Outcome; Vulvar Neoplasms	2004
Detection of human papillomavirus (HPV) 16-specific CD4+ T-cell immunity in patients with persistent HPV16-induced vulvar intraepithelial neoplasia in relation to clinical impact of imiquimod treatment. Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Jul-15, Volume: 11, Issue:14 Topics: Adjuvants, Immunologic; Adult; Aged; Aminoquinolines; Carcinoma in Situ; CD4-Positive T-Lymphocytes; Female; Humans; Imiquimod; Immunity, Cellular; Interferon-gamma; Middle Aged; Papillomaviridae; Treatment Outcome; Vulvar Neoplasms	2005
Fluorouracil does not improve the outcome of imiquimoid treatment of vulval intraepethelial neoplasia. Acta dermato-venereologica, 2005, Volume: 85, Issue:4 Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Drug Therapy, Combination; Female; Fluorouracil; Humans; Imiquimod; Prospective Studies; Treatment Outcome; Vulvar Neoplasms	2005
Final results of a phase 2 study using continuous 5% Imiquimod cream application in the primary treatment of high-grade vulva intraepithelial neoplasia. Gynecologic oncology, 2007, Volume: 106, Issue:3 Topics: Administration, Topical; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Female; Humans; Imiquimod; Middle Aged; Vulvar Neoplasms	2007
Topical imiquimod can reverse vulvar intraepithelial neoplasia: a randomised, double-blinded study. Gynecologic oncology, 2007, Volume: 107, Issue:2 Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Double-Blind Method; Female; Humans; Imiquimod; Middle Aged; Pain; Prospective Studies; Treatment Outcome; Vulvar Neoplasms	2007
Treatment of vulvar intraepithelial neoplasia with topical imiquimod. The New England journal of medicine, 2008, Apr-03, Volume: 358, Issue:14 Topics: Administration, Topical; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Biopsy; Carcinoma in Situ; DNA, Viral; Female; Follow-Up Studies; Humans; Imiquimod; Middle Aged; Papillomaviridae; Papillomavirus Infections; Quality of Life; Vulvar Neoplasms	2008
The effects of 5% imiquimod cream on high-grade vulval intraepithelial neoplasia. Gynecologic oncology, 2002, Volume: 85, Issue:1 Topics: Administration, Topical; Adult; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Middle Aged; Ointments; Precancerous Conditions; Prospective Studies; Vulvar Neoplasms	2002

Other Studies

66 other study(ies) available for imiquimod and Vulvar Neoplasms

Article	Year
The Paget Trial: topical 5% imiquimod cream for noninvasive vulvar Paget disease. American journal of obstetrics and gynecology, 2022, Volume: 227, Issue:2 Topics: Aminoquinolines; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Imiquimod; Paget Disease, Extramammary; Quality of Life; Vulvar Neoplasms	2022
Topical imiquimod as first-line treatment for vulvar intraepithelial neoplasia. Lancet (London, England), 2022, 05-07, Volume: 399, Issue:10337 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Female; Humans; Imiquimod; Vulvar Neoplasms	2022
Vulvar Paget's disease: outcomes of 51 patients treated with imiquimod cream. Maturitas, 2022, Volume: 163 Topics: Antineoplastic Agents; Breast Neoplasms; Female; Humans; Imiquimod; Paget Disease, Extramammary; Retrospective Studies; Vulvar Neoplasms	2022
The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) consensus statem International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2022, 07-04, Volume: 32, Issue:7 Topics: Carcinoma in Situ; Cidofovir; Colposcopy; Female; Genital Neoplasms, Female; Humans; Imiquimod; Melanoma; Melanoma, Cutaneous Malignant; Paget Disease, Extramammary; Pregnancy; Skin Neoplasms; Vulvar Neoplasms	2022
The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) Consensus Statem Journal of lower genital tract disease, 2022, Jul-01, Volume: 26, Issue:3 Topics: Carcinoma in Situ; Colposcopy; Female; Humans; Imiquimod; Melanoma; Melanoma, Cutaneous Malignant; Paget Disease, Extramammary; Pregnancy; Skin Neoplasms; Squamous Intraepithelial Lesions; Vulvar Neoplasms	2022
A pre-existing coordinated inflammatory microenvironment is associated with complete response of vulvar high-grade squamous intraepithelial lesions to different forms of immunotherapy. International journal of cancer, 2020, 11-15, Volume: 147, Issue:10 Topics: Adjuvants, Immunologic; Adult; Aged; Case-Control Studies; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Count; Female; Humans; Imiquimod; Immunotherapy; Middle Aged; Myeloid Cells; Neoplasm Grading; Squamous Intraepithelial Lesions; Treatment Outcome; Tumor Microenvironment; Vulvar Neoplasms	2020
Paget's Disease of the Vulva: A Review of 20 Years' Experience. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2017, Volume: 27, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Logistic Models; Middle Aged; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Vulvar Neoplasms	2017
Human Papillomavirus DNA Methylation Predicts Response to Treatment Using Cidofovir and Imiquimod in Vulval Intraepithelial Neoplasia 3. Clinical cancer research : an official journal of the American Association for Cancer Research, 2017, Sep-15, Volume: 23, Issue:18 Topics: Aminoquinolines; Biomarkers; Carcinoma in Situ; Cidofovir; Cytosine; DNA Methylation; DNA, Viral; Drug Therapy, Combination; Female; Genes, Viral; Humans; Imiquimod; Neoplasm Staging; Organophosphonates; Papillomaviridae; Papillomavirus Infections; Promoter Regions, Genetic; ROC Curve; Treatment Outcome; Vulvar Neoplasms	2017
Is cidofovir a better treatment than imiquimod for high-grade vulval intraepithelial neoplasia? BJOG : an international journal of obstetrics and gynaecology, 2018, Volume: 125, Issue:9 Topics: Carcinoma in Situ; Cidofovir; Female; Humans; Imiquimod; Neoplasm Recurrence, Local; Vulvar Neoplasms	2018
Imiquimod cream and C02 laser vaporization in vulvar intraepithelial neoplasia (VIN) 2/3 treatment. European journal of gynaecological oncology, 2017, Volume: 38, Issue:3 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Female; Humans; Imiquimod; Lasers, Gas; Ointments; Vulvar Neoplasms	2017
Genital Warts, Lymphangioma, and Treatment with Imiquimod. Actas dermo-sifiliograficas, 2018, Volume: 109, Issue:7 Topics: Adult; Antineoplastic Agents; Condylomata Acuminata; Diagnosis, Differential; Female; Humans; Imiquimod; Lymphangioma; Vulvar Neoplasms	2018
Successful treatment of high-grade vulval intra-epithelial neoplasia with imiquimod 5% in a renal transplant recipient. International journal of STD & AIDS, 2019, Volume: 30, Issue:2 Topics: Administration, Topical; Antineoplastic Agents; Carcinoma in Situ; Female; Humans; Imiquimod; Immunosuppression Therapy; Kidney; Kidney Transplantation; Middle Aged; Ointments; Papillomaviridae; Papillomavirus Infections; Transplant Recipients; Treatment Outcome; Tumor Virus Infections; Vulva; Vulvar Neoplasms	2019
Management of vulval melanoma in situ with imiquimod. The British journal of dermatology, 2019, Volume: 180, Issue:4 Topics: Administration, Topical; Aged; Antineoplastic Agents; Biopsy; Female; Humans; Imiquimod; Melanoma; Microscopy, Confocal; Treatment Outcome; Vulva; Vulvar Neoplasms	2019
Vulvar Paget disease: A national retrospective cohort study. Journal of the American Academy of Dermatology, 2019, Volume: 81, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Disease-Free Survival; Female; Humans; Imiquimod; Kaplan-Meier Estimate; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Netherlands; Paget Disease, Extramammary; Retrospective Studies; Survival Rate; Vulvar Neoplasms; Vulvectomy	2019
Impact of smoking on imiquimod response in patients with vulval intraepithelial neoplasia. Clinical and experimental dermatology, 2019, Volume: 44, Issue:4 Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aged; Aged, 80 and over; Carcinoma in Situ; Female; Humans; Imiquimod; Middle Aged; Papillomavirus Infections; Retrospective Studies; Smoking; Treatment Outcome; Vulvar Neoplasms	2019
Extensive extramammary Paget's disease of the vulva involving the bladder postradical split skin graft reconstruction. BMJ case reports, 2019, Mar-09, Volume: 12, Issue:3 Topics: Aged, 80 and over; Antineoplastic Agents; Cystoscopy; Female; Gynecologic Surgical Procedures; Humans; Imiquimod; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Skin Transplantation; Urethral Neoplasms; Urinary Bladder Neoplasms; Vulvar Neoplasms	2019
A Case of Chronic and Relapsing Paget Disease of the Vulva. Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia, 2019, Volume: 41, Issue:6 Topics: Aged; Antineoplastic Agents; Female; Humans; Imiquimod; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Plastic Surgery Procedures; Treatment Outcome; Vulvar Neoplasms; Vulvectomy	2019
Imiquimod 5% cream versus cold knife excision for treatment of VIN 2/3: a five-year follow-up. European review for medical and pharmacological sciences, 2013, Volume: 17, Issue:7 Topics: Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Female; Follow-Up Studies; Humans; Imiquimod; Neoplasm Recurrence, Local; Ointments; Vulvar Neoplasms	2013
Vulvar and vaginal HPV disease. Obstetrics and gynecology clinics of North America, 2013, Volume: 40, Issue:2 Topics: Adolescent; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Colposcopy; Condylomata Acuminata; Female; Human papillomavirus 11; Human papillomavirus 6; Humans; Imiquimod; Interferon Inducers; Middle Aged; Neoplasm Recurrence, Local; Papillomavirus Infections; Papillomavirus Vaccines; Podophyllotoxin; Pregnancy; Pregnancy Complications, Infectious; Sexually Transmitted Diseases; Trichloroacetic Acid; Vaginal Diseases; Vaginal Neoplasms; Vaginal Smears; Vulvar Diseases; Vulvar Neoplasms; Young Adult	2013
Treatment of extramammary Paget disease of the vulva with imiquimod: a retrospective, multicenter study by the German Colposcopy Network. Journal of the American Academy of Dermatology, 2014, Volume: 70, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Aminoquinolines; Analysis of Variance; Antineoplastic Agents; Cohort Studies; Colposcopy; Female; Follow-Up Studies; Germany; Humans; Imiquimod; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Paget Disease, Extramammary; Retrospective Studies; Risk Assessment; Survival Rate; Treatment Outcome; Vulvar Neoplasms	2014
Treatment of primary vulvar paget disease with 5% imiquimod cream. Journal of lower genital tract disease, 2014, Volume: 18, Issue:4 Topics: Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Middle Aged; Paget Disease, Extramammary; Skin Cream; Treatment Outcome; Vulvar Neoplasms	2014
Surgery or topical therapy for vulval intraepithelial neoplasia. The Lancet. Oncology, 2014, Volume: 15, Issue:12 Topics: Aminoquinolines; Carcinoma in Situ; Cidofovir; Cytosine; Female; Humans; Imiquimod; Organophosphonates; Vulvar Neoplasms	2014
Adjuvant topical treatment with imiquimod 5% after excisional surgery for VIN 2/3. European review for medical and pharmacological sciences, 2014, Volume: 18, Issue:19 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Combined Modality Therapy; Female; Humans; Imiquimod; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Risk Factors; Vulvar Neoplasms	2014
Usual vulval intraepithelial neoplasia in HIV-positive women - a case series. International journal of STD & AIDS, 2016, Volume: 27, Issue:14 Topics: Adult; Aged; Aminoquinolines; Anti-HIV Agents; Antineoplastic Agents; CD4 Lymphocyte Count; Female; HIV Seropositivity; Humans; Imiquimod; Middle Aged; Retrospective Studies; Treatment Outcome; Uterine Cervical Dysplasia; Vulvar Neoplasms	2016
Topical imiquimod in the treatment of extramammary Paget's disease: A 10 year retrospective analysis in an Asian tertiary centre. Dermatologic therapy, 2016, Volume: 29, Issue:6 Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biopsy; Female; Humans; Imiquimod; Male; Paget Disease, Extramammary; Penile Neoplasms; Retrospective Studies; Singapore; Skin Cream; Sweat Gland Neoplasms; Tertiary Care Centers; Time Factors; Treatment Outcome; Vulvar Neoplasms	2016
Imiquimod for vulvar intraepithelial neoplasia. The New England journal of medicine, 2008, Jul-03, Volume: 359, Issue:1 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Chemotherapy, Adjuvant; Female; Humans; Imiquimod; Papillomavirus Infections; Secondary Prevention; Vulvar Neoplasms	2008
Imiquimod for vulvar intraepithelial neoplasia. The New England journal of medicine, 2008, Jul-03, Volume: 359, Issue:1 Topics: Aminoquinolines; Antineoplastic Agents; Anus Neoplasms; Carcinoma in Situ; Female; Humans; Imiquimod; Papillomaviridae; Papillomavirus Infections; Viral Load; Vulvar Neoplasms	2008
Imiquimod in vulvar Paget's disease: a case report. The Journal of reproductive medicine, 2008, Volume: 53, Issue:10 Topics: Aged, 80 and over; Aminoquinolines; Female; Humans; Imiquimod; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Remission Induction; Treatment Outcome; Vulvar Neoplasms	2008
Multidisciplinary treatment of vulval extramammary Paget's disease to maintain sexual function: an imiquimod success story. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2009, Volume: 29, Issue:3 Topics: Aminoquinolines; Antineoplastic Agents; Combined Modality Therapy; Female; Humans; Imiquimod; Middle Aged; Paget Disease, Extramammary; Sexual Behavior; Vulvar Neoplasms	2009
Mammary and extramammary Paget's disease: a study of 14 cases and the associated therapeutic difficulties. Clinics (Sao Paulo, Brazil), 2009, Volume: 64, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Male; Middle Aged; Paget Disease, Extramammary; Paget's Disease, Mammary; Prostatic Neoplasms; Vulvar Neoplasms	2009
Successful treatment of three cases of primary extramammary Paget's disease of the vulva with Imiquimod--proposal of a therapeutic schedule. Journal of the European Academy of Dermatology and Venereology : JEADV, 2010, Volume: 24, Issue:4 Topics: Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Drug Administration Schedule; Female; Humans; Imiquimod; Middle Aged; Paget Disease, Extramammary; Remission Induction; Skin Neoplasms; Vulvar Neoplasms	2010
Vulvar cancer. Skin changes not to be ignored. Mayo Clinic health letter (English ed.), 2010, Volume: 28, Issue:6 Topics: Administration, Topical; Age Factors; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Female; Humans; Imiquimod; Laser Therapy; Middle Aged; Precancerous Conditions; Risk Factors; Vulvar Neoplasms	2010
Nonsteroidal anti-inflammatory drugs do not interfere with imiquimod treatment for usual type vulvar intraepithelial neoplasia. International journal of cancer, 2011, May-15, Volume: 128, Issue:10 Topics: Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Biopsy; Carcinoma in Situ; Cell Separation; Drug Interactions; Female; Flow Cytometry; Fluorescent Dyes; Humans; Imiquimod; Immunohistochemistry; Vulvar Neoplasms	2011
Non-responders to topical imiquimod followed by vaccination therapy in VIN patients may be due to the level of IL10. British journal of cancer, 2010, Aug-10, Volume: 103, Issue:4 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Clinical Trials as Topic; Female; Humans; Imiquimod; Interleukin-10; Vulvar Neoplasms	2010
Post-surgical treatment of melanoma in situ of the vulva with imiquimod. Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2010, Volume: 32, Issue:8 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Combined Modality Therapy; Female; Humans; Imiquimod; Melanoma; Vulvar Neoplasms	2010
Vulvar puritus for one year. Dermatology online journal, 2010, Oct-15, Volume: 16, Issue:10 Topics: Aminoquinolines; Antineoplastic Agents; Diagnosis, Differential; Female; Humans; Imiquimod; Middle Aged; Paget Disease, Extramammary; Pruritus Vulvae; Vaginal Creams, Foams, and Jellies; Vulvar Neoplasms	2010
A case of usual (basaloid)-type vulvar intraepithelial neoplasia that failed to respond to imiquimod cream: clinical implications. International journal of clinical oncology, 2011, Volume: 16, Issue:5 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Drug Resistance, Neoplasm; Female; Humans; Imiquimod; Middle Aged; Neoplasm Staging; Treatment Failure; Vulvar Neoplasms	2011
Imiquimod-induced clearance of HPV is associated with normalization of immune cell counts in usual type vulvar intraepithelial neoplasia. International journal of cancer, 2010, Dec-15, Volume: 127, Issue:12 Topics: Adult; Aminoquinolines; Antineoplastic Agents; Biomarkers, Tumor; Carcinoma in Situ; Case-Control Studies; Cyclin-Dependent Kinase Inhibitor p16; DNA, Viral; Female; Humans; Imiquimod; Immunoenzyme Techniques; Lymphocyte Count; Middle Aged; Papillomaviridae; Papillomavirus Infections; Polymerase Chain Reaction; Prognosis; Vulvar Neoplasms; Young Adult	2010
[Extramammary Paget disease treated with 5% imiquimod cream]. Actas dermo-sifiliograficas, 2011, Volume: 102, Issue:7 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Paget Disease, Extramammary; Pharmaceutical Preparations; Vulvar Neoplasms	2011
Clinical treatment of vulvar Paget's disease: a case report. Clinics (Sao Paulo, Brazil), 2011, Volume: 66, Issue:6 Topics: Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biopsy; Female; Humans; Imiquimod; Paget Disease, Extramammary; Time Factors; Treatment Outcome; Vulvar Neoplasms	2011
Cutaneous mucinous carcinoma arising in extramammary Paget disease of the perineum. The American Journal of dermatopathology, 2011, Volume: 33, Issue:7 Topics: Adenocarcinoma, Mucinous; Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Neoplasms, Multiple Primary; Paget Disease, Extramammary; Perineum; Skin Neoplasms; Vulvar Neoplasms	2011
Conservative management of extramammary paget disease with imiquimod. Journal of lower genital tract disease, 2012, Volume: 16, Issue:1 Topics: Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Middle Aged; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Skin Neoplasms; Treatment Outcome; Vulva; Vulvar Neoplasms	2012
Treatment of locally recurrent mucosal melanoma with topical imiquimod. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Nov-20, Volume: 29, Issue:33 Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Male; Melanoma; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Vaginal Neoplasms; Vulvar Neoplasms	2011
Treatment of multifocal Bowen's disease in immunocompromised women with surgery and topical imiquimod. Obstetrics and gynecology, 2012, Volume: 119, Issue:2 Pt 2 Topics: Adult; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Female; HIV Infections; Humans; Imiquimod; Immunocompromised Host; Skin Neoplasms; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vulvar Neoplasms	2012
Vulvar intraepithelial neoplasia: evaluation of treatment modalities. Journal of lower genital tract disease, 2012, Volume: 16, Issue:3 Topics: Administration, Topical; Adult; Aged; Aminoquinolines; Biopsy, Needle; Carcinoma in Situ; Cohort Studies; Female; Follow-Up Studies; Gynecologic Surgical Procedures; Humans; Imiquimod; Immunohistochemistry; Laser Therapy; Lasers, Gas; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Portugal; Retrospective Studies; Risk Assessment; Treatment Outcome; Vulvar Neoplasms; Young Adult	2012
Sustained remission of extramammary Paget disease following treatment with imiquimod 5% cream. Actas dermo-sifiliograficas, 2012, Volume: 103, Issue:8 Topics: Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Dosage Forms; Female; Humans; Imiquimod; Middle Aged; Paget Disease, Extramammary; Remission Induction; Vulvar Neoplasms	2012
Vulvar intraepithelial neoplasia (VIN 2/3): comparing clinical outcomes and evaluating risk factors for recurrence. Gynecologic oncology, 2012, Volume: 127, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Combined Modality Therapy; Female; Humans; Imiquimod; Laser Therapy; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Neoplasm Staging; Proportional Hazards Models; Retrospective Studies; Risk Factors; Treatment Outcome; Vulva; Vulvar Neoplasms; Young Adult	2012
Treatment of vulvar intraepithelial neoplasia with topical 5% imiquimod cream. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2013, Volume: 120, Issue:3 Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Female; Follow-Up Studies; Human papillomavirus 16; Humans; Imiquimod; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Papillomavirus Infections; Remission Induction; Retrospective Studies; Treatment Outcome; Vaginal Creams, Foams, and Jellies; Vulvar Neoplasms	2013
Successful treatment of vulvar intraepithelial neoplasia with topical imiquimod 5% cream in a lung transplanted patient. Acta dermato-venereologica, 2002, Volume: 82, Issue:6 Topics: Administration, Topical; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Female; Humans; Imiquimod; Papillomaviridae; Papillomavirus Infections; Treatment Outcome; Tumor Virus Infections; Vulvar Neoplasms	2002
Successful treatment of a high-grade intraepithelial neoplasia with imiquimod, with vulvar pemphigus as a side effect. European journal of obstetrics, gynecology, and reproductive biology, 2003, Aug-15, Volume: 109, Issue:2 Topics: Adjuvants, Immunologic; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Female; Genital Neoplasms, Female; Humans; Imiquimod; Papillomaviridae; Papillomavirus Infections; Pemphigus; Treatment Outcome; Uterine Cervical Neoplasms; Vaginal Neoplasms; Vulvar Diseases; Vulvar Neoplasms	2003
Successful treatment of recurrent extramammary Paget's disease of the vulva with topical imiquimod 5% cream. Journal of the American Academy of Dermatology, 2003, Volume: 49, Issue:4 Topics: Adjuvants, Immunologic; Aged; Aminoquinolines; Female; Humans; Imiquimod; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Vulvar Neoplasms	2003
Detection of CD8+ T cell responses to human papillomavirus type 16 antigens in women using imiquimod as a treatment for high-grade vulval intraepithelial neoplasia. Gynecologic oncology, 2004, Volume: 92, Issue:1 Topics: Adult; Amino Acid Sequence; Aminoquinolines; Antibodies, Viral; Antibody Specificity; Antigens, Viral, Tumor; Antineoplastic Agents; CD8-Positive T-Lymphocytes; DNA, Viral; Female; Humans; Imiquimod; Interferon-gamma; Molecular Sequence Data; Oncogene Proteins, Viral; Papillomaviridae; Papillomavirus E7 Proteins; Repressor Proteins; Vulvar Neoplasms	2004
Imiquimod contact pemphigus: a comment. European journal of obstetrics, gynecology, and reproductive biology, 2004, Aug-10, Volume: 115, Issue:2 Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Clobetasol; Contraceptives, Oral; Female; Humans; Imiquimod; Papillomavirus Infections; Pemphigus; Treatment Outcome; Vulvar Diseases; Vulvar Neoplasms	2004
Treatment of external genital warts with 5% imiquimod cream during pregnancy: a case report. BJOG : an international journal of obstetrics and gynaecology, 2004, Volume: 111, Issue:12 Topics: Administration, Topical; Adult; Aminoquinolines; Antineoplastic Agents; Condylomata Acuminata; Female; Humans; Imiquimod; Ointments; Pregnancy; Pregnancy Complications, Infectious; Vulvar Neoplasms	2004
Grade 3 vulvar and anal intraepithelial neoplasia in a HIV seropositive child--therapeutic result: case report. Clinical and experimental obstetrics & gynecology, 2005, Volume: 32, Issue:2 Topics: Administration, Topical; Aminoquinolines; Anti-HIV Agents; Anus Neoplasms; Carcinoma; Child; Combined Modality Therapy; Female; Follow-Up Studies; HIV Infections; HIV Seropositivity; Humans; Imiquimod; Immunocompromised Host; Low-Level Light Therapy; Papillomavirus Infections; Risk Assessment; Treatment Outcome; Vulvar Neoplasms	2005
Successful treatment of vulvar Bowen's disease with topical imiquimod 5% cream. International journal of dermatology, 2006, Volume: 45, Issue:2 Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Female; Humans; Imiquimod; Skin Neoplasms; Vulvar Neoplasms	2006
Preliminary results of 5% imiquimod cream in the primary treatment of vulva intraepithelial neoplasia grade 2/3. American journal of obstetrics and gynecology, 2006, Volume: 194, Issue:2 Topics: Adjuvants, Immunologic; Adult; Aged; Aminoquinolines; Carcinoma in Situ; Colposcopy; Female; Humans; Imiquimod; Middle Aged; Prospective Studies; Remission Induction; Vulvar Neoplasms	2006
Successful treatment of vulval melanoma in situ with topical 5% imiquimod cream. The British journal of dermatology, 2006, Volume: 155, Issue:1 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Melanoma; Precancerous Conditions; Vulvar Neoplasms	2006
Treatment of vulvar intraepithelial neoplasia using topical imiquimod 5% cream in a genitourinary medicine clinic setting. International journal of STD & AIDS, 2007, Volume: 18, Issue:1 Topics: Administration, Topical; Adult; Ambulatory Care Facilities; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Female; Humans; Imiquimod; Vulvar Neoplasms	2007
HPV-related vulvar intraepithelial neoplasia: outcome of different management modalities. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2007, Volume: 99, Issue:1 Topics: Adjuvants, Immunologic; Adult; Aged; Aminoquinolines; Carcinoma in Situ; Catheter Ablation; Female; Follow-Up Studies; Humans; Imiquimod; Laser Therapy; Middle Aged; Papillomavirus Infections; Precancerous Conditions; Retrospective Studies; Treatment Outcome; Vulvar Neoplasms	2007
Letter to the Editor concerning "Topical imiquimod can reverse vulvar intraepithelial neoplasia: a randomized, double blinded study." Gynecologic Oncology 107 (2007) 219-222. Gynecologic oncology, 2008, Volume: 109, Issue:3 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Double-Blind Method; Female; Humans; Imiquimod; Randomized Controlled Trials as Topic; Vulvar Neoplasms	2008
Complete resolution of Paget disease of the vulva with imiquimod cream. Journal of lower genital tract disease, 2008, Volume: 12, Issue:2 Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Biopsy; Female; Follow-Up Studies; Humans; Imiquimod; Male; Ointments; Paget Disease, Extramammary; Vaginal Creams, Foams, and Jellies; Vulvar Neoplasms	2008
Self-administered topical imiquimod treatment of vulvar intraepithelial neoplasia. A report of four cases. The Journal of reproductive medicine, 2000, Volume: 45, Issue:8 Topics: Adjuvants, Immunologic; Administration, Cutaneous; Adult; Aminoquinolines; Carcinoma in Situ; Condylomata Acuminata; Drug Administration Schedule; Female; Humans; Imiquimod; Middle Aged; Neoplasm Recurrence, Local; Ointments; Papillomaviridae; Self Administration; Tumor Virus Infections; Vulvar Neoplasms	2000
Clinical and molecular responses in high-grade intraepithelial neoplasia treated with topical imiquimod 5%. Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:10 Topics: 2',5'-Oligoadenylate Synthetase; Administration, Topical; Adult; Aminoquinolines; Antineoplastic Agents; Female; Follow-Up Studies; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Genital Neoplasms, Female; Humans; Imiquimod; Middle Aged; Ointments; RNA, Neoplasm; Time Factors; Treatment Outcome; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vaginal Neoplasms; Vulvar Neoplasms	2001
Successful topical immunotherapy of bowenoid papulosis with imiquimod. The British journal of dermatology, 2001, Volume: 145, Issue:6 Topics: Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Female; Humans; Imiquimod; Interferon Inducers; Vulvar Neoplasms	2001
Treatment of vulvar intraepithelial neoplasia 2/3 with imiquimod. The Journal of reproductive medicine, 2002, Volume: 47, Issue:5 Topics: Administration, Cutaneous; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Disease-Free Survival; Female; Humans; Imiquimod; Medical Records; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Texas; Treatment Outcome; Vulvar Neoplasms	2002